AbbVie (ABBV) Debt Ratio (2012 - 2026)
AbbVie (ABBV) posted quarterly Debt Ratio of 0.47 for Q1 2026, down 5.72% year-over-year from 0.5 in Q1 2025, and down 2.54% quarter-over-quarter from 0.49 in Q4 2025.
AbbVie (ABBV) Debt Ratio (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported Debt Ratio for 15 consecutive years, with 0.47 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt Ratio fell 5.72% year-over-year to 0.47; the TTM figure through Mar 2026 stood at 0.47 (down 5.72% YoY), while the FY2025 annual figure was 0.49, up 8.68% from the prior year.
- Debt Ratio declined to 0.47 in Q1 2026 per ABBV's latest filing, from 0.49 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.51 in Q1 2022 and bottomed at 0.41 in Q2 2023.
- Historically, Debt Ratio has averaged 0.47 across 5 years, with a median of 0.47 in 2025.
- On a YoY basis, Debt Ratio climbed as much as 7115.12% in 2022 and fell as far as 23.21% in 2022.
- AbbVie's Debt Ratio stood at 0.46 in 2022, then slipped by 3.29% to 0.44 in 2023, then increased by 1.27% to 0.45 in 2024, then climbed by 8.68% to 0.49 in 2025, then retreated by 2.54% to 0.47 in 2026.
- Business Quant data shows ABBV's Debt Ratio at 0.47 in Q1 2026, 0.49 in Q4 2025, and 0.49 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 0.08 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 0.25 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 0.66 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -0.31 |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.52 |
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 0.49 |
| Sep 30, 2025 | 0.49 |
| Jun 30, 2025 | 0.47 |
| Mar 31, 2025 | 0.50 |
| Dec 31, 2024 | 0.45 |
| Sep 30, 2024 | 0.50 |
| Jun 30, 2024 | 0.50 |
| Mar 31, 2024 | 0.50 |
| Dec 31, 2023 | 0.44 |
| Sep 30, 2023 | 0.45 |
| Jun 30, 2023 | 0.41 |
| Mar 31, 2023 | 0.46 |
| Dec 31, 2022 | 0.46 |
| Sep 30, 2022 | 0.49 |
| Jun 30, 2022 | 0.43 |
| Mar 31, 2022 | 0.51 |
| Dec 31, 2021 | 0.44 |
| Sep 30, 2021 | 0.01 |